Respiratory

Latest News

Wildfire smoke | Image credit: Aleksandr Lesik - stock.adobe.com
Smoke Pollution Linked to Increase in Hospitalizations in Older Adults

April 30th 2025

Respiratory diseases made up the hospitalizations in older adults after they were exposed to wildfire smoke.

cigarettegraphic | Image Credit: © freshidea-stock.adobe.com
Health Gains From US Smoking Decline Fall Short of Expectations

April 28th 2025

Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B that has shown promise in IPF and PPF. | Image credit: Елена Бутусова - stock.adobe.com
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

February 13th 2025

Sanofi | Image credit: Eagle - stock.adobe.com
Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

December 16th 2024

Group of diverse kids | Image Credit: © EKKAPON-stock.adobe.com
Ambient Toxins Linked to Disabilities in Minority Schoolchildren

December 10th 2024

Continuing Medical Education
View All
April 30th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Gunnar Esiason, patient advocate, Florence Healthcare
September 30th 2022

Contributor: It’s Time to Talk About Paying Clinical Trial Participants More

Gunnar Esiason
There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.
Child using nebulizer
September 28th 2022

CDC to Physicians: Watch for Severe Respiratory, Polio-Like Illness in Children

Allison Inserro
The CDC this week noted what providers and parents have been seeing across the country: rising cases of a non-polio enterovirus causing severe respiratory illness and acute flaccid myelitis (AFM).
What We're Reading
September 7th 2022

What We’re Reading: Expanding Monkeypox Vaccine Access; Annual COVID-19 Boosters; Juul to Pay in Teen Marketing Settlement

AJMC Staff
Under a new contract with AmerisourceBergen Corp, HHS will expand access to monkeypox vaccines and treatments; as President Jow Biden encouraged Americans to receive their COVID-19 boosters this fall, the White House signaled toward annual COVID-19 boosters; Juul has reached a settlement with 37 states and Puerto Rico regarding the company’s marketing to teens.
elderly patient getting a shot
September 1st 2022

Older Adults Benefit From High-Dose Influenza Vaccine

Laura Joszt, MA
A high-dose influenza vaccine reduces the risk of death and incidence of hospitalization for influenza and pneumonia among older adults.
graphic of antibiotic
August 28th 2022

Short-Course Antibiotic Therapy for Community-Acquired Pneumonia as Effective as Long-Course Therapy

Rose McNulty
The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate community-acquired pneumonia.
Image of vaccine solution
August 26th 2022

Pfizer Touts 85% Efficacy of RSV Vaccine for Adults, Will Seek FDA Approval

Allison Inserro
In the phase 3 trial, Pfizer’s vaccine was 85.7% effective against respiratory syncytial virus (RSV) defined by 3 or more symptoms among older adults.
N95 Mask
August 18th 2022

COVID-19 Is at Peak Infectiousness for 5 Days After Symptom Onset

Julia Bonavitacola
A recent cohort study found that two-thirds of patients could transmit SARS-CoV-2 at 5 days since their symptoms began; the median infectiousness duration in the sample was 5 days.
Woman coughing
August 11th 2022

Frequent Productive Cough Associated With Worse Outcomes in Asthma, COPD

Alisha Lekh
Frequent productive cough was experienced by patients with asthma and/or chronic obstructive pulmonary disease (COPD), with symptom prevalence increasing with higher disease severity, according to the results of a recent study.
COVID-19 molecule
August 9th 2022

ILD Associated With Higher Risk of COVID-19 Severity, Mortality

Alisha Lekh
Interstitial lung disease (ILD) was shown to correlate with an increased risk of both COVID-19 severity and mortality, according to a recent meta-analysis.
Up arrow
August 3rd 2022

Incidence, Mortality, Costs Increased Among Medicaid Patients With NVHAP

Alisha Lekh
A recent study calculated the incidence and mortality rates for patients with Medicaid coverage who had nonventilator hospital-acquired pneumonia (NVHAP) and found possible associations between greater health care costs and NVHAP diagnosis.
Image of lungs
July 31st 2022

Nutrition, Pneumonia Severity May Predict Life Expectancy From Aspiration Pneumonia

Lindsey Mulrooney
Poor nutritional status and increased severity of pneumonia were associated with higher mortality rates among patients with aspiration pneumonia, according to a recent study.
woman touching throat before coughing
July 28th 2022

Coughing Triggered by Mechanical Stimulation Suggests New Type of Cough Sensitization

Lindsey Mulrooney
Mechanical stimulation, including finger pressure on discrete areas of the chest wall and neck, triggered reproducible coughing in about 50% of patients with chronic cough, indicating that chronic cough may be caused by the central convergence of somatic and visceral neural stimuli.
Person smoking e-cigarette
July 23rd 2022

Social Media Exposure to Tobacco Content Associated With Increased Tobacco Use

Lindsey Mulrooney
People exposed to tobacco content on social media were more likely to report tobacco use than those who were not, according to a recent meta-analysis. The investigators called for regulation of social media marketing in the tobacco industry.
Vaccine syringe and vials
July 19th 2022

Vaccine Candidate Effective in Preventing Against RSV, Phase 2a Study Finds

Alisha Lekh
Results from a phase 2a study show that a bivalent prefusion F vaccine was effective against symptomatic respiratory syncytial virus (RSV) infection and viral shedding, with no identified safety concerns.
Image of lungs
July 10th 2022

Reduced Lung Function Linked to High Levels of Ambient, Household Air Pollution

Lindsey Mulrooney
The study is one of the first to analyze the negative impact of particulate matter and the use of biomass fuel on lung function for young adults in lower–middle income countries.
Hospital beds
July 7th 2022

Age, Sex, Kidney Disease Predict Mortality for Patients Hospitalized With Respiratory Diseases

Lindsey Mulrooney
A recent study found that older age, male sex, residence in a long-term care home, and chronic kidney disease were shared predictors of increased mortality for patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2.
marijuana
July 1st 2022

ED Visits, Hospitalizations 22% Higher Among Cannabis Users

Lindsey Mulrooney
Emergency department (ED) visits and hospitalizations were 22% higher among cannabis users, with acute trauma and respiratory-related reasons as the primary causes for emergency care.
person filling out form
June 24th 2022

Identifying Consistent Characteristics Among Patients With Refractory, Unexplained Chronic Cough

Hayden E. Klein
Individuals with refractory or unexplained chronic cough had characteristics consistent of those with chronic cough in general, including cough duration, severity, and 24-hour frequency.
girl wearing face mask
June 17th 2022

Researchers Analyze Long-term Symptoms of COVID-19, Pneumonia, Flu

Hayden E. Klein
COVID-19 may not be the only respiratory infection that can result in chronic symptoms afterward.
Roxana Siles, MD, FAAAAI, Cleveland Clinic
June 14th 2022

Dr Roxana Siles: QOL Improves Greatly From Effective Chronic Cough Treatment

Maggie L. Shaw
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, address the impact of effective treatments of chronic cough on patient quality of life (QOL).
What We're Reading: GSK Close to RSV Vaccine; Health Care CEOs Back Gun Legislation; COVID-19 and Infant Development
June 10th 2022

What We're Reading: GSK Close to RSV Vaccine; Health Care CEOs Back Gun Legislation; COVID-19 and Infant Development

AJMC Staff
GlaxoSmithKline (GSK) aims to have its respiratory syncytial virus (RSV) vaccine reviewed later this year; Northwell Health and Kaiser Permanente among CEOs supporting gun legislation; Infants whose mothers had COVID-19 during their pregnancy had double the risk of delayed speech or motor skills.
Woman vaping
June 9th 2022

Vaping Injuries Associated With Long-term Respiratory Problems, Study Finds

Julia Bonavitacola
A new study found that patients with e-cigarette or vaping–associated lung injury had a higher risk of developing respiratory disability, cognitive impairment, symptoms of depression, anxiety, and posttraumatic stress within 1 year of their injury.
scan of lung
June 2nd 2022

Research Suggests COVID-19 Vaccines May Protect Against Pneumonia

Hayden E. Klein
Chest computed tomography scans demonstrated a lower frequency of pneumonia in fully vaccinated patients compared with unvaccinated patients, with a significantly lower frequency among patients who received the Pfizer vaccine.
lungs image and a stethoscope
May 27th 2022

COVID-19 Survivors at Increased Risk for Pulmonary Embolism, Respiratory Symptoms

Laura Joszt, MA
US adults who survived a COVID-19 infection are more likely than individuals who were not infected with COVID-19 to develop incident conditions attributable to the virus.
person smoking electronic cigarette
May 26th 2022

e-Cigarette Use Linked to $15 Billion in Health Care Expenses in 2018

Hayden E. Klein
In 2018, annual health care expenditures attributable to current e-cigarette use totaled $15.1 billion or $2024 per person, according to researchers.
Roxana Siles, MD, FAAAAI, Cleveland Clinic
May 22nd 2022

Dr Roxana Siles: We Need to Address the Needs of Patients With Refractory/Unexplained Cough

Maggie L. Shaw
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, discusses the important need for chronic cough therapies and what issues with current treatments should be addressed by next-generation medications.
child coughing
May 20th 2022

High Proportions of Deaths Among Infants, Children Linked to RSV, Researchers Find

Hayden E. Klein
Researchers also found that 95% of respiratory syncytial virus (RSV)-associated acute lower respiratory infection episodes and more than 97% of RSV-attributable deaths were among children in low– and middle-income countries.
toothbrush with toothpaste
May 11th 2022

Oral Hygiene Reduces Chance of Ventilator-Associated Pneumonia in ICU Patients, Study Shows

Hayden E. Klein
Oral care decreased both the number of intensive care unit (ICU) patients and the length of stay, as well as the amount of time of mechanical ventilation.
Roxana Siles, MD, FAAAAI, Cleveland Clinic
May 6th 2022

Dr Roxana Siles: Blinded Trials Are Important When Evaluating Chronic Cough Treatment

Maggie L. Shaw
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the placebo effect seen in clinical trials of chronic cough treatment.
woman coughing
May 1st 2022

Simple Surveys May Help Phenotype and Target Treatment for Chronic Cough

Rose McNulty
A study of the Austrian general population found that most chronic cough cases could be assigned a phenotype through a simple survey-based assessment that could help target treatment to individual cases.
<123456789
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo